Safety of Empagliflozin in Drug Naive T2D PatientsSafety of Empagliflozin in Drug Naive T2D Patients

Could this SGLT2 inhibitor help to successfully manage type 2 diabetes in previously untreated patients -- without increasing cardiometabolic risk? Cardiovascular Diabetology

Source: Medscape Today Headlines - February 10, 2016 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news